SCHEMBL25527358

SCHEMBL25527358

CCNc1nc2ccc(C=O)cc2cc1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGK1 P00558 1/20 0.41
FGFR1 P11362 3/20 0.40
SRC P12931 1/20 0.40
PSMB5 P28074 4/20 0.40
KDM4E B2RXH2 2/20 0.39
POLB P06746 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
KMT2A Q03164 1/20 0.39
IP6K1 Q92551 1/20 0.38
GAA P10253 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
JAK2 O60674 1/20 0.36
IKBKB O14920 1/20 0.35
CHUK O15111 1/20 0.35
KDR P35968 2/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25527205 0.80 ALDH1A1 (0.41) PGK1KDM4EALDH1A1MEN1KMT2A
SCHEMBL6995100 0.74 ALDH1A1 (0.42) KDM4EPOLBALDH1A1MEN1NPC1
SCHEMBL9881010 0.71 ALDH1A3 (0.36) ALDH1A1GAA
SCHEMBL28962063 0.68 KMT2A (0.48) FGFR1PSMB5KDM4EKMT2ANPSR1
SCHEMBL30600413 0.67 ALDH1A1 (0.50) KDM4EPOLBALDH1A1MEN1NPC1
SCHEMBL10494663 0.67 ALDH1A1 (0.50) KDM4EPOLBALDH1A1MEN1NPC1
SCHEMBL13681886 0.67 RXFP1 (0.37) KDM4EPOLBALDH1A1MEN1NPC1
SCHEMBL11971651 0.67 KDM4E (0.48) KDM4EPOLBALDH1A1MEN1KMT2A
SCHEMBL3263288 0.67 ACP1 (0.52) FGFR1KDM4EALDH1A1NPC1NPSR1
SCHEMBL13681867 0.67 RXFP1 (0.41) KDM4EPOLBALDH1A1MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159510-A1 NOVEL PRMT5 INHIBITORS AMGEN INC. (US) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159510-A1 NOVEL PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 PGK1 905/4885FGFR1 2558/4885SRC 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.